Olivier Loeillot sold $536k of RGEN
Chief Executive Officer at REPLIGEN CORP. 3,832 shares at an average of $140.00, traded Apr 21, 2026, filed Apr 22, 2026.
Score components
- +25RoleCEO
- +19Trade size$536k at market
- 0Share of holdings soldSold 6.6% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.5%, 3m +12.6%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-169682, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 21, 2026 | SOpen-market sale Common Stock10b5-1 | -3,832 | $140.00 | $536k | 54,246 | Apr 22, 2026 |
Related signals
Other insiders at REPLIGEN CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $1.0M 5,535 shares | -12% | |
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $2.5M 12,946 shares | -23% | |
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $977k 5,426 shares | -10% | |
| 23Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $504k 3,035 shares | -6% | |
| 15Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $977k 5,426 shares | -9% | |
| 11Weak | REPLIGEN CORP | Jason K Garland CFO | $80k 530 shares | -3% | |
| 12Weak | REPLIGEN CORP | Jason K Garland CFO | $106k 733 shares | -4% | |
| 21Weak | RGENsell REPLIGEN CORP | Karen A Dawes director | $44k 275 shares | -0% | |
| 50Moderate | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $1.2M 7,041 shares | -16% | |
| 50Moderate | REPLIGEN CORP | James Bylund Chief Operating Officer | $331k 2,191 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.